Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: An effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity

Neuroscience Letters

Volumn 383, Issue 3, 2005, Pages 209-214

  Erb, Suzanne ^a   Funk, Douglas ^b   Lê, Anh Dzung ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Bed nucleus of the stria terminalis; Central nucleus of the amygdala; Corticotropin releasing factor; Intracerebroventricular; Sensitization; Stress

Indexed keywords

BIOLOGICAL MARKER; COCAINE; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; PROTEIN C FOS; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REACTION TIME; SENSITIZATION; STATISTICAL SIGNIFICANCE; STRESS; STRIA TERMINALIS;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; COCAINE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; GENE EXPRESSION; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 20444423325     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.04.013     Document Type: Article

References (28)

1. G.F. Alheid, J.S. de Olmos, and C.A. Beltramino Amygdala and extended amygdala G. Paxinos The Rat Nervous System 1995 Academic Press San Diego 495 578
2. A. Badiani, M. Oates, H. Day, S. Watson, H. Akil, and T. Robinson Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty J. Neurosci. 18 1998 10579 10593
3. J. Bittencourt, and P. Sawchenko Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor systems J. Neurosci. 20 2000 1142 1156
4. M. Cador, B.J. Cole, G.F. Koob, L. Stinus, and M. Le Moal Central administration of corticotropin releasing factor induces long-term sensitization to d-amphetamine Brain Res. 606 1993 181 186
5. C. Chang, N. Wang, and M. Lin Inhibition of the dopamine system in rat amygdala attenuates the picrotoxin-induced locomoter hyperactivity and hypertension Clin. Exp. Pharmacol. Physiol. 31 2004 284 288
6. W. Cullinan, J. Herman, D. Battaglia, H. Akil, and S. Watson Pattern and time course of immediate early gene expression in rat brain following acute stress Neuroscience 64 1995 477 505
7. M. Davis, D. Walker, and Y. Lee Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352 1997 1675 1687
8. J.M. Delfs, Y. Zhu, J.P. Druhan, and G. Aston-Jones Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion Nature 403 2000 430 434
9. S. Erb, D. Funk, and A. Le Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin- releasing factor (CRF) in rats Psychopharmacology 170 2003 383 389
10. S. Erb, V. Lopak, and C. Smith Cocaine pre-exposure produces a sensitized and context-specific c-fos mRNA response to footshock stress in the central nucleus of the amygdala Neuroscience 129 2004 719 725
11. S. Erb, N. Salmaso, D. Rodaros, and J. Stewart A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats Psychopharmacology 158 2001 360 365
12. S. Erb, J. Stewart, A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking, J. Neurosci. 19 (1999) RC35, 1-6.
13. D.L. Gelowitz, and L. Kokkinidis The effects of amygdaloid stimulation on amphetamine-elicited locomotor sensitization Brain Res. Bull. 32 1993 561 565
14. S. Heinrichs, F. Menzaghi, G. Schulteis, G. Koob, and L. Stinus Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal Behav. Pharmacol. 6 1995 74 80
15. T. Imaki, T. Shibasaki, M. Hotta, and H. Demura Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress Brain Res. 616 1993 114 125
16. T. Imaki, T. Shibasaki, A. Mauda, H. Demura, K. Shizume, and N. Ling Effects of adrenergic blockers on corticotropin-releasing factor-induced behavioural changes in rats Regul. Pept. 19 1987 243 251
17. G.F. Koob Corticotropin-releasing factor, norepinephrine, and stress Biol. Psychiatry 46 1999 1167 1180
18. E.H. Lee, and M.J. Tsai The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice Behav. Neural Biol. 51 1989 412 423
19. I. Matsuzaki, Y. Takamatsu, and T. Moroji The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the Central Nervous System: behavioural and biochemical studies Neuropeptides 13 1989 147 155
20. F. Menzaghi, S. Rassnick, S. Heinrichs, H. Baldwin, M. Merlo Pich, F. Weiss, and G.F. Koob The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal Ann. N.Y. Acad. Sci. 739 1994 176 184
21. O. Pucilowski, E. Trzaskowska, W. Kostowski, and L. Valzelli Norepinephrine-mediated suppression of apomorphine-induced aggression and locomotor activity in the rat amygdala Pharmacol. Biochem. Behav. 26 1987 217 222
22. S. Rassnick, S.C. Heinrichs, K.T. Britton, and G.F. Koob Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal Brain Res. 605 1993 25 32
23. R. Sakai, L. Ma, P. He, and S. Fluharty Intracerebraoventricular administration of angiotensin type 1 (AT1) receptor antisense oligonucleotides attenuate thirst in the rat Regul. Pept. 59 1995 183 192
24. Z. Sarnyai, E. Biro, J. Gardi, M. Vecsernyés, J. Julesz, and G. Telegdy Brain cortiocotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats Brain Res. 657 1995 89 97
25. Z. Sarnyai, Y. Shaham, and S.C. Heinrichs The role of corticotropin-releasing factor in drug addiction Pharmacol. Rev. 53 2001 209 243
26. Y. Shaham, S. Erb, and J. Stewart Stress-induced relapse to heroin and cocaine seeking in rats: a review Brain Res. Rev. 33 2000 13 33
27. C.J. Slawecki, C. Somes, and C.L. Ehlers Effects of chronic ethanol exposure on neurophysiological responses to corticotropin releasing factor and neuropeptide Y Alcohol Alcohol. 34 1999 289 299
28. J.R. Walker, S.H. Ahmed, K.N. Gracy, and G.F. Koob Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats Brain Res. 854 2000 85 92